GlaxoSmithKline LLC v. Glenmark Pharmaceuticals Inc., USA
1:14-cv-00877
Overview
Parties
Defendant
Glenmark Pharmaceuticals Inc., USA Operating Company
Represented By
7 Attorneys ListedHeyman Enerio Gattuso & Hirzel LLP
222 Delaware Avenue, Suite 900
Pashman Stein Walder Hayden P.C.
824 North Market Street, Suite 800
Glenmark Generics Inc. USA Operating Company
Represented By
4 Attorneys ListedPashman Stein Walder Hayden P.C.
824 North Market Street, Suite 800
Plaintiff
SmithKline Beecham (Cork) Limited NPE (University / Research)
Represented By
4 Attorneys Listed1261 W. Bridge St
1261 W. Bridge St, Spring City, PA 19422
Baker & Hostetler LLP
1201 N. Market Street, Ste #1407
Cooley LLP
30 S. 9th Street, 7th Floor
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
GlaxoSmithKline LLC NPE (University / Research)
Represented By
10 Attorneys Listed1261 W. Bridge St
1261 W. Bridge St, Spring City, PA 19422
Baker & Hostetler LLP
1201 N. Market Street, Ste #1407
Cooley LLP
30 S. 9th Street, 7th Floor
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
No Co-Pending Disputes Detected in Current Index
There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
USRE40000
Method of treatment for decreasing mortality resulting from congestive heart failure
|
Filed: 2003-11-25
Issued: 2008-01-08
|
Expired (Term Ended)
Expires: 2023-11-25
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
28
Dispositive
15
Granted
1
Denied
0
Pending / Review
27
Motions by Category
Key Dispositive Motions & Rulings